VanEck Biotech ETF Rating → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free BBH Stock Alerts $163.64 +0.16 (+0.10%) (As of 10:36 AM ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media VanEck Biotech ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy2.60Holdings in BBH have an aggregate rating of Moderate Buy based on 399 analyst ratings issued in the past year covering 25 companies (100.1% of the portfolio).BBH Aggregate Price Target$191.5317.16% UpsideHigh Prediction$253.18Average Prediction$191.53Low Prediction$137.97Holdings in BBH have an aggregate price target of $191.53 and a range of $137.97 to $253.18 covering 25 companies (100.1% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.02%AMGNAmgen$310.94+1.2%5 of 5 stars2.52$305.05 -1.9%21Earnings ReportAnalyst ForecastAnalyst Revision9.32%VRTXVertex Pharmaceuticals$417.19-0.4%4 of 5 stars2.48$432.18 3.6%25Earnings ReportAnalyst Forecast7.81%REGNRegeneron Pharmaceuticals$962.71+0.7%4 of 5 stars2.70$981.71 2.0%207.45%GILDGilead Sciences$64.73-0.3%5 of 5 stars2.39$83.69 29.3%186.54%MRNAModerna$124.30+2.0%4 of 5 stars2.25$126.89 2.1%16Earnings ReportAnalyst ForecastAnalyst Revision4.57%ARGXargenx$376.61-2.5%3 of 5 stars2.71$528.16 40.2%21News Coverage4.51%BIIBBiogen$220.50+0.4%5 of 5 stars2.65$290.92 31.9%264.49%IQVIQVIA$228.60+0.3%5 of 5 stars2.80$257.57 12.7%15Gap Down4.17%ILMNIllumina$111.10+0.4%5 of 5 stars2.30$164.65 48.2%20Earnings ReportAnalyst ForecastAnalyst Revision4.13%ICLRICON Public$313.15+0.4%4 of 5 stars3.00$339.44 8.4%8Positive News3.28%BGNEBeiGene$168.27+2.3%3 of 5 stars2.80$250.13 48.6%10Earnings ReportNews CoveragePositive News2.80%NBIXNeurocrine Biosciences$139.60+0.4%5 of 5 stars2.74$147.88 5.9%23Analyst Revision2.76%BMRNBioMarin Pharmaceutical$81.89+0.1%5 of 5 stars2.63$107.50 31.3%19Insider Selling2.53%SRPTSarepta Therapeutics$130.00-1.9%4 of 5 stars2.79$160.60 23.5%14Insider SellingAnalyst Revision2.44%CRLCharles River Laboratories International$228.32-3.0%5 of 5 stars2.64$253.23 10.9%11Gap Up2.42%TECHBio-Techne$78.01+1.2%4 of 5 stars2.82$80.50 3.2%112.37%NTRANatera$93.50-2.3%2 of 5 stars3.00$86.40 -7.6%142.26%BNTXBioNTech$93.08+3.3%3 of 5 stars2.27$118.82 27.7%11Analyst ForecastOptions VolumeNews Coverage2.00%QGENQiagen$43.43+1.1%4 of 5 stars2.56$50.95 17.3%9Analyst Revision1.98%EXASExact Sciences$53.12-10.7%4 of 5 stars2.92$99.07 86.5%13News CoverageHigh Trading Volume1.96%ALNYAlnylam Pharmaceuticals$151.11-0.8%5 of 5 stars2.59$216.19 43.1%17Earnings ReportAnalyst Forecast1.77%INCYIncyte$53.24-0.5%5 of 5 stars2.47$74.93 40.7%17Gap Down1.72%RGENRepligen$164.10-0.8%4 of 5 stars2.89$197.75 20.5%9Analyst Revision0.89%CRSPCRISPR Therapeutics$52.37-1.7%3 of 5 stars2.38$77.23 47.5%17Earnings ReportAnalyst ForecastNews CoverageGap Down0.86%CYTKCytokinetics$63.96-2.0%3 of 5 stars2.87$79.33 24.0%15Earnings ReportAnalyst ForecastInsider SellingNews CoverageGap Up This page (NASDAQ:BBH) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
